Michael J Fox receives Medal of Freedom from President Biden

At a ceremony at The White House on 4 January, Michael J Fox was among 19 new recipients of the Presidential Medal of Freedom.
06 January 2025 Laura Vickers-Green
News

Michael J Fox was among 19 new recipients of the Presidential Medal of Freedom at a White House ceremony earlier this week.

US President Joe Biden awarded the medals, which are the country’s highest civilian honour, presented to individuals who have made exemplary contributions to the prosperity, values, or security of the United States.

During a ceremony on Saturday 4 January 2025, Michael J Fox received enthusiastic cheers as he was presented with his medal, with a White House representative reading the following statement about his notable contributions to America:

The Presidential Medal of Freedom is awarded to Michael J Fox… one of the most beloved actors of our time. With remarkable wit and charm, he introduced iconic characters to the centre of American culture, from Alex P Keaton to Marty McFly, and more.

With undaunted resilience and optimism, he also warms hearts and captivates audiences as a fearless advocate for those with Parkinson’s, channeling his endearing personality to advance treatments, move us closer to a cure, and remind us of the power of American possibilities.

Watch a video of Michael J Fox receiving his medal from President Biden below:

Fox released the following statement on the website of the Michael J Fox Foundation:

“Receiving the Presidential Medal of Freedom is humbling, an honor I could never have anticipated. I’m grateful for this recognition, which I share with the patients, families and researchers who have brought us closer than ever to ending Parkinson’s disease once and for all.”

Fox established the Michael J Fox Foundation in 2000, after disclosing his Parkinson’s diagnosis in 1991, and the Foundation has since raised more than $2 billion for Parkinson’s research projects. This included the significant breakthrough of discovering a Parkinson’s biomarker in 2023, and collaborating with the Critical Path for Parkinson’s Consortium (including representatives from Parkinson’s Europe) on a new staging framework for Parkinson’s, which was launched in early 2024.

This isn’t the first time Michael J Fox has been honoured for his contributions to the global Parkinson’s community. In 2023, he received an honorary Oscar, the Jean Hersholt Humanitarian Award, for his work fighting Parkinson’s. He also won a Lifetime Achievement Award at the 2024 Media Access Awards, and was named one of Time‘s 2024 list of influential people in health.

Aside from Michael J Fox, other recipients of the Presidential Medal of Freedom in 2025 included former Secretary of State Hillary Clinton, U2 front-man Bono, actor Denzel Washington, and fashion designer Ralph Lauren.

Image credit: 358897408 | Michael Fox © Fred Duval | Dreamstime.com

3 things we want to see in 2025

Here we outline our three main hopes for the Parkinson’s community as we step into a new year
01 January 2025 Sarah Dawson
Insights

The start of a new year offers the perfect opportunity to take stock and look to the future. In 2025, Parkinson’s Europe is committed to driving change for those living with Parkinson’s.

Through campaigns for improved and more personalised care to global initiatives to empower the worldwide Parkinson’s community, here are the three areas where we’d like to see change in 2025.

1. For the EU to listen to our call to action about improving Parkinson’s care in Europe

nurse holding patient's hand

At the start of 2024, Parkinson’s Europe and AbbVie co-hosted a roundtable on the topic of care pathways for people with advanced Parkinson’s. Expert panellists from all over Europe, including movement disorder specialists, nurses, researchers, people with Parkinson’s and representatives of Parkinson’s organisations, all shared their insights around care pathways for advanced Parkinson’s. The roundtable highlighted four common areas for improvements, inspiring our Parkinson’s Europe call to action.

“The call to action is aimed at European policy makers, calling for the improvement of Parkinson’s treatment and care,” explains Francesco De Renzis, Partnership Project Manager for Parkinson’s Europe. “In 2025, we aim to use this CtA as a lobbying tool to raise awareness of these topics and push decision makers to invest more resources in supporting neurodegenerative healthcare workforces across Europe, to achieve higher standards of care for people with Parkinson’s, regardless of where they live.”

2. More real-world data to understand the bigger picture of Parkinson’s in Europe

scientist looking through microscope

While research into Parkinson’s is on-going, this year we want to see a more joined-up approach, using real-world data to effectively advocate for the Parkinson’s community.

Amelia Hursey, Research Manager at Parkinson’s Europe says: “We need data to give strength to any argument we make to improve the lives of people with Parkinson’s. There are huge amounts of health and real-world Parkinson’s-related data in Europe, however it’s not all linked together. If we can harmonise the appropriate bits of data together, we can use that to engage with decision makers at all levels, helping them to understand why issues need to be addressed and how Parkinson’s impacts the European community.”

You can read about our Parkinson’s Engagement Network and what we’ve achieved in 2024 here.

3. Even more global collaboration to empower the Parkinson’s community across the world

older couple sitting on sofa smiling

If we really want to drive change, we need to do it together, At Parkinson’s Europe we recognise how crucial it is to work with the global experts and those engaged in Parkinson’s worldwide, to be able to make impactful progress. 2024 has seen some amazing initiatives relating to Parkinson’s across the globe, the most recent of which being the National Plan to End Parkinson’s in the USA.

Parkinson’s Europe Research Manager, Amelia Hursey, believes we need to keep building on this momentum: “We joined the Critical Path for Parkinson’s initiative in 2023, and from this became a member of the NeuroImpact Coalition in 2024, which is an initiative led by patient organisations across the globe. Being part of this work enables us to make sure that the voice of the European Parkinson’s community is represented and listened to. We know the needs and challenges of each Parkinson’s community in the countries of Europe are distinct and unique, therefore needing to be recognised in the new developments that are happening.”

What are your hopes for 2025? Let us know in the comments!

Year in Review: 10 highlights from 2024

As the year wraps up, we take a moment to reflect on the highlights of 2024 with our Parkinson's Life Year in Review
18 December 2024 Sarah Dawson
News

It’s been a massive year for the Parkinson’s community, from the awareness-raising World Parkinson’s Day 2024 and innovative gender-specific studies to the epic sporting challenges undertaken by those living with Parkinson’s.

Here are 10 of our favourite and most-read stories from Parkinson’s Life in 2024

1. A new staging framework for Parkinson’s

In January a groundbreaking new Parkinson’s framework was published in a paper in The Lancet, after being developed by the Critical Path for Parkinson’s Consortium (CPP).

Hailed as a “major step” in Parkinson’s research, the new framework aims to help define and stage Parkinson’s based on biology, rather than symptoms. Using two medical tests in clinical trials – which you can read more about here – the proposal looks to help identify Parkinson’s in people even before symptoms appear.

Similar to the Predict-PD research project – which this year surpassed its goal to recruit 10,000 participants – being able to begin clinical trials in people with Parkinson’s who aren’t even showing physical symptoms is part of the ongoing effort to develop the scientific knowledge to help identity, treat and ultimately cure Parkinson’s.

2. Firsts for women in Parkinson’s

Year in review - firsts for women with Parkinson's
Richelle Flanagan (centre) with Professor Aideen Sullivan (left) and Research fellow Lucy Collins-Stack of the University College Cork

2024 saw the launch of innovative studies and initiatives championing tailored research into the ways Parkinson’s uniquely affects women. In March we spoke with Richelle Flanagan, a woman with Parkinson’s and inventor of the Parkinson’s self-care app My Moves Matter, who collaborated on Ireland’s University College Cork’s study investigating hormonal fluctuation in women with Parkinson’s.

More recently, we covered the news of a landmark global initiative, Gender Equitable Medicines for Parkinson’s Disease, working to advance actionable research on how Parkinson’s affects women. All positive steps towards a more equitable approach to detection, disease management and therapies for those living with Parkinson’s.

3. A new website for Parkinson’s Europe

A screenshot of the new Parkinson's Europe website showing the navigation bar and the interactive map

March saw the launch of our new and improved Parkinson’s Europe website. From an easy-to-navigate homepage to exclusive member area for Parkinson’s Europe Member Organisations to access and share resources, everything was designed to help people with Parkinson’s, healthcare professionals and Parkinson’s organisations find the information they need easily.

Parkinson’s Life – Parkinson’s Europe’s online magazine – was added to the main website and continues to be a go-to hub for the Parkinson’s community. The revamped website also saw the inclusion of an interactive Parkinson’s map, where users can discover local Parkinson’s groups and hear about important events.

4. World Parkinson’s Day 2024

World Parkinson's Day Year in review

Across the world, the Parkinson’s community came together to make World Parkinson’s Day 2024 one to remember. Global landmarks were lit up to mark the occasion and raise awareness, Parkinson’s Europe launched their Summer of Sport and the podcast legends The Movers and Shakers presented their ‘Parky Charter’ to the UK Prime Minister at 10 Downing Street. It was an impressive world-wide effort to raise funds and awareness on all things Parkinson’s related.

5. National Plan to End Parkinson’s Act in the US

Congress has passed the National Plan to End Parkinson's Act in the USA

June saw the National Plan to End Parkinson’s Act passed unanimously by the US Senate. This historic bill is the USA’s first-ever federal legislation dedicated to ending Parkinson’s disease, including things like increasing research funding, improving early diagnosis, and enhancing public awareness of Parkinson’s.

The news was welcomed enthusiastically by the Parkinson’s community across America, leaving the question: how can Europe learn from the National Plan to End Parkinson’s Act, and bring about something similar for the European Parkinson’s community?

6. A person with Parkinson’s was an Olympic torch-bearer

Anthony Desjardins, Olympic torch bearer for Paris 2024

We all know that representation matters, especially when the eyes of the world are watching. In May this year, 41-year-old Anthony Desjardins – diagnosed with Parkinson’s in 2021 – was chosen to carry the Paris 2024 Olympic Flame through his home city of Montpellier, France.
With over 10,000 followers, Anthony uses his social media accounts to talk about the benefits of sports and exercise for Parkinson’s.

Describing representing Parkinson’s on Paris 2024’s world stage as “an honour” Anthony said: “ I’m as happy to carry the torch for myself as I am to carry it for the entire Parkinson’s community.”

7. People with Parkinson’s did some amazing sporting challenges

A photo of Gary Shaughnessy during one of his many Parkinson's exercise challenges

Ready to make 2025 the year you get more active? Take inspiration from Parkinson’s Europe Summer of Sport, and these people with Parkinson’s who are pushing themselves to their limits by taking on incredible exercise challenges.

From the World’s Toughest Row race to epic 450km bike rides, we spoke to 12 men and women who’ve really gone the extra mile for Parkinson’s. Just four days after World Parkinson’s Day 2024, Frenchmen Bertrand Delhom became the first person with Parkinson’s to sail around the world and we shared his story here.

8. Beech Band invention

Carl Beech and Nick Whiteley with their prototype of the Beech Band

Diagnosed with Young-Onset Parkinson’s just last year, 51-year-old Carl Beech has already made waves in the Parkinson’s community with the Beech Band – a clever gadget to help control speech issues. The wearable wrist band device replicates the tapping technique he used to help him with his Parkinson’s related stammer.

“I found out that not only a beat but tapping myself had a profound impact,” Carl explained. “I realised the comforting and distracting nature of it took my mind off the problem.” He set about designing an accessible device that can be used by those with fine motor control issues, and the Beech Band was born. Now in the manufacturing process, Carl hopes the first batch of Beech Bands will be available to buy early 2025. Watch this space!

9. We helped launch a new Parkinson’s book

Front cover image of new book What Parkinson's Feels Like

Artist Barbara Salsberg Mathews was inspired to use her talents to give a voice to the Parkinson’s community this year. Using descriptions written by people with Parkinson’s about what it’s like to live with the condition, Barbara has transformed their words into emotive illustrations for a new e-book, What Parkinson’s Feels Like.

Barbara hopes the e-book will build empathy and raise awareness about Parkinson’s. She says: “Reading these descriptions reminded me that I’m not alone. I could never have created this booklet without the descriptions of all those who shared their lived experiences with Parkinson’s.”

You can download the book for free here in either English, Spanish, French, Italian, German, Ukrainian or Russian. There’s also the option to donate to one of three Parkinson’s charities, including Parkinson’s Europe.

10. Improving care for people with advanced Parkinson’s

A person with advanced Parkinson's discussing care with a medical professional

At the start of the year Parkinson’s Europe and AbbVie held a roundtable for global experts in the field to talk about how to improve care for people in the advanced stages of Parkinson’s.

Inadequate resources and availability of expert staff, the crucial role Parkinson’s nurses play in improving care, and how those living with advanced Parkinson’s in rural areas aren’t receiving the same level of care as those living in cities, were all topics that featured highly in our roundtable discussions. To drive change, we’re launching a petition for people to pledge to our resulting “Call to Action”, aimed at European policymakers.

What was your highlight of 2024? Share with us on your social media platform of choice (search “Parkinson’s Europe” to find us).

Person with Parkinson’s is developing new drug treatment

Frenchman with Parkinson’s Guillaume Brachet is working 70 hours a week to develop a new Parkinson’s drug treatment
13 December 2024 Verity Willcocks
News

Despite having an incurable condition, many people with Parkinson’s refuse to be beaten, whether it’s taking up incredible physical feats, raising thousands in cash for research, or making huge efforts to raise awareness. But after being diagnosed with young onset Parkinson’s at just 29 years of age in 2018, Guillaume Brachet, from near Tours in France, is going one step further: he is trying to develop a new drug to treat people with Parkinson’s.

The idea came to Guillaume, who has a phD in biology and has worked as a medical biologist, a pharmacist and as an assistant lecturer, after he read a scientific paper by Leuven university.

Guillaume Brachet

“I was looking for some hope,” says Guillaume, who says he has read more than 700 scientific articles about Parkinson’s. “I was reading the scientific literature about Parkinson’s disease to gain insight into where the science was, [to find out] if there was some hope for some [new] treatment in the time frame of my life, if it was something that I wouldn’t be able to expect for the upcoming years or decades.”

Guillaume developed a theory that a combination of various existing medications might have the potential to create a disease-modifying formula for people with Parkinson’s. He then spent six months approaching pharmaceutical companies with a 60-page rationale for his theory. But after being told more research was required, Guillaume realised he needed to raise money to fund the laboratory-based research required to move the project forward.

This was the motivation behind his 2022 ‘Parkinson sur Loire’ challenge, which saw Guillaume kayak 150km along the Loire. “‘Parkinson sur Loire’ was against the flow, from the ocean, up the river, because it was a metaphor of sports against Parkinson’s,” says Guillaume.

Guillaume on his ‘Parkinson Sur Loire’ challenge in 2024

After he raised 45,000 euros during the gruelling challenge, two Marseilles-based research organisations Neuron Experts and Syncrosome matched it with another 45,000 euros of funding.

After the laboratory-based research yielded promising results in April 2023, Guillaume launched his own drug development company CXS Therapeutics five months later. A subsidiary company Sappiens is about to be launched, which will focus on the development of the potential new Parkinson’s drug. It was patented earlier this year as CXS003, and Guillaume hopes that it may be able to slow the progression of the condition.

As CEO of both companies, Guillaume works nearly 70 hours a week as he works towards phase 2 trials of CXS003 taking place next year. He hopes that if it is proved to be safe and effective, a potential new Parkinson’s treatment could be available in 2029.

Find out more about Parkinson’s research

7 new Parkinson’s books in English, Italian and Dutch

From emotive illustrated stories to fascinating memoirs and picture books for children, here are 7 new Parkinson’s book worth adding to your 2024 reading list
04 December 2024 Sarah Dawson
Advice

Building on our popular series of Parkinson’s book recommendations from spring and summer this year, we wanted to share even more suggestions for new Parkinson’s books to add to your reading list this winter.

While other roundups have featured a wide mix of books in multiple languages, including Spanish, Greek, Czech and French, these new releases are predominantly in English, with one Italian selection and one Dutch. If your language isn’t included here, do look at our original roundup which features an inclusive list of titles for much of our European audience.

As always, we’d love to hear from you. Please do keep your recommendations of new Parkinson’s books coming – either tag us on social media, or send us an email with details to [email protected]

Parkinson’s Books in multiple languages

What Parkinson's Feels Like book cover

What Parkinson’s Feels Like by Barbara Salsberg Mathews

Diagnosed with Parkinson’s in 2020, artist Barbara Salsberg Mathews was inspired to use her creative talents to give a voice to the Parkinson’s community. Collecting descriptions written by people with Parkinson’s around the globe about what it’s like to live with condition, Barbara has transformed their words into emotive and impactful illustrations. What Parkinson’s Feels Like was created to build empathy, inform and raise awareness about Parkinson’s. It’s a unique book that deserves a spot on every bookcase.

Download the book for free here in either English, Spanish, French, Italian, German, Ukranian or Russian.

Parkinson’s Books in English

Grandpa Used to Drive Big Trucks book cover

Grandpa Used to Drive Big Trucks written by Martha Nance and Steve Witebsky, illustrated by Matthew Karren

Co-written by a neurologist specialising in Parkinson’s disease and a grandfather living with it, Grandpa Used to Drive Big Trucks is a charming picture book perfect for children aged three to eight years. Packed with engaging illustrations and age-appropriate language about Parkinson’s, this heartwarming story aims to open up conversations and cover tough topics in a child-friendly way.

Buy for £19.21 on Itasca Books or Amazon (US only).

I will CURE my Parkinson's book cover

I will CURE my Parkinson’s by Lisa Bradbury

Australian wellbeing specialist Lisa Bradbury was diagnosed with young-onset Parkinson’s disease (YOPD) when she was just 48 years old. Finding her way through the complex world of medical treatments and alternative therapies, I will CURE my Parkinson’s is Lisa’s self-help guide, empowering those living with Parkinson’s to advocate for their health and make informed decisions when it comes to treatment – both scientific and holistic.

Buy for £6.11 on Amazon.

Movement disorders volume 8 book cover

Movement Disorders in Neurology and Systemic Disorders (Volume 8) edited by Pramod Kumar Pal and Ali Shalash

The latest release in the International Review of Movement Disorders series focuses on the ever-advancing device-aided therapies in Parkinson’s disease. It’s a comprehensive read at 450 pages and features a collection of chapters written by global experts in the field. Bringing together specialists in neurology and Parkinson’s from around the world, it shines a light on the advances being made in Parkinson’s therapies.

Buy for £178 on WH Smith or Amazon.

three Nines Fine book cover

Three Nines Fine: A Journey with Brain Health by Alanah Rochelle Knibb and Omotola Thomas

This powerful and beautifully illustrated graphic novel tells the story of Asabi, a woman diagnosed with YOPD, who decides to move her family from Africa to the UK. Struggling with her diagnosis, the move and motherhood, she turns to her aunt, who is living with Lewy body dementia, to find answers and support. Inspired by true events, and supported by Alzheimer’s Research UK’s Inspire Fund, this book offers a fresh and insightful perspective on the connection between Parkinson’s and Lewy body dementia, as well as sharing everyday ways we can improve our own brain health.

Buy for £12 on Amazon.

Parkinson’s Books in Italian

Raccontare e il mio mestiere book cover
Raccontare è il Mio Mestiere by Giangi Milesi

As the President of Parkinson Italia, Giangi Milesi gives an authentic insight into his life and career as a leading figure in the Italian NGO sector. This fascinating memoir – translated as ‘Telling is My Job’ – is an inspiring read into the challenges of a life spent championing the third sector, and the search for meaning in a complex, modern world.

Buy for €18 on Scatole Parlanti.

Parkinson’s Books in Dutch

Leven Met Parkinson book

 

Leven Met Parkinson by Frank Schopman

Frank Schopman’s candid account of living with Parkinson’s is uplifting, moving and deeply personal. From his diagnosis nine years ago at 52 (after both his mother and brother were diagnosed), to having to leave his job as a teacher due to the symptoms, Leven Met Parkinson showcases Schopman’s positive spirit as he focusses ‘not on what Parkinson’s does to you, but what do you do with Parkinson’s.’

Buy for €16.99 on Uitgeverij Abessijn.

If you’ve got any recommendations of new Parkinson’s books, email us at [email protected]

TwinBrain: what new ‘brain in motion’ technology can reveal about Parkinson’s

How ground-breaking medical imaging is helping EU-funded researchers monitor brain activity during movement – and what this could mean for diagnosing and treating Parkinson’s
28 November 2024 Sarah Dawson
Stories

Neuroimaging has made huge strides in trying to demystify the human brain, but there’s still so much to discover. While most studies have been conducted under stationary conditions – usually with the participants lying down – a three-year research initiative is taking a more dynamic approach. The EU-funded TwinBrain – ‘Twinning the brain with machine learning for neuro-muscular efficiency’ – project, coordinated by Slovenian scientists, has developed game-changing technology to monitor a patient’s brain activity while they move around their environment.

The brain is a powerful multitasker, working hard behind the scenes while we all get on with our daily lives. But it’s exactly this type of day-to-day brain activity which TwinBrain is keen to explore further. Investigating what is going on in the brain as we walk, balance or run has been a big challenge for neuroscientists. However, innovative new technology developed by the TwinBrain project now makes it possible to monitor new areas of the brain while in movement.

Someone running on a treadmill

The brain in motion

Led by Dr Uroš Marušič, senior research associate at the Science and Research Centre in Koper, Slovenia, and head of the Slovenian Mobile Brain/Body Imaging Lab – SloMoBIL, the TwinBrain research has been studying the brain during everyday activities, with the hope of picking up the early signs of disorders that affect brain-to-body coordination, like Parkinson’s.

The initiative has been a global collaboration, bringing together researchers from the Technical University of Berlin in Germany, the University of Trieste in Italy and the University of Geneva in Switzerland.

Together they have developed cutting-edge technology called mobile brain/body imaging (MoBI). This advanced imaging allows specialists to monitor the brain and body movement simultaneously, making it possible to spot any signs of neurological issues and – crucially – start treatments earlier.

older woman doing exercise

The MoBI technology, developed in 2021 in Berlin, combines electroencephalogram (EEG) technology, a test that measures electrical activity in the brain, with electromyography (EMG) which measures muscle response or electrical activity in response to a nerve’s stimulation of the muscle. Simply put by Dr Marušič, “We can now measure what is going on in the brain while you are walking, running, or doing other types of physical or mental activity.”

As part of the TwinBrain initiative, this MoBI technology was transferred from Germany to Slovenia, while neurologists and researchers from Italy and Switzerland have further enhanced its performance.

What this means for Parkinson’s

The TwinBrain initiative is focused on making strides in the diagnosis and treatment of complex neurological conditions that affect movement, including Parkinson’s.

Speaking to Horizon – the EU Research and Innovation Magazine – Dr. Marušič explains: “In early-stage Parkinson’s, behind the scenes, the brain is compensating for balance and movement deficiencies. This can lead to a person tripping or falling.” The hope is that MoBI will offer a more comprehensive look at exactly what is going on in the brain during this ‘multi-task’.

Paolo Manganotti, a professor of neurology at the University of Trieste, was involved in the recruitment and testing of volunteers for the TwinBrain study, with 57 participants taking part in MoBI testing since 2021. Manganotti found that participants were very willing to take part to “help improve outcomes not only for themselves, but also for future patients.”

Speaking to Horizon magazine, Paolo Manganotti said: “TwinBrain offers groundbreaking insights for clinical practice. By integrating the latest technology, we can revolutionise the diagnosis and monitoring of Parkinson’s disease within a few years, increasing patient satisfaction and their quality of life.”

scientific illustration of the brain

Looking to the future

Dr. Marušič is keen to continue advancing the MoBI technology with on-going research though the TBrainBoost project and new research partners from across Europe.

Ultimately, the aim is for the TwinBrain initiative to result in earlier and more advanced treatment with people living with Parkinson’s and other neurological disorders.

For Dr Marušič this is all about personalised healthcare. Speaking to Horizon magazine, he said, “I want patients to be able to come to one place to address all issues at the same time. Personalised centres offering diagnostics and treatments tailored to your needs – one place that does it all.”

Amelia Hursey, Research Manager for Parkinson’s Europe, is also keen to see how this new technology and research can be used to help with early diagnosis, adding: “Any new technological development that may help us to detect Parkinson’s early is exciting. We hope that the research being done to see if these measures can be used for Parkinson’s as a supportive biomarker are successful.”

To find out more about TwinBrain visit the project website here.

Artistry with Parkinson’s: “While I was painting, the tremors ceased”

Artist Kanti Khanna on discovering her gift for painting after her Parkinson's diagnosis
25 November 2024 Charu Bahri
Stories

“So what if I’ve got Parkinson’s?” Kanti Khanna says was her first thought after being diagnosed with Parkinson’s 16 years ago, at the age of 64. Kanti has lived in Birmingham since 1968, when she travelled to the UK for the first time as a newly-wed Indian bride.

“You might as well have told me I’d got the flu. I wouldn’t have reacted differently,” says Kanti. “I’d already had tremors in my left hand for a couple of years. Something I had chosen not to think about until it got to a point when my family and friends insisted that I see my GP.”

When the diagnosis was made, Kanti says, “Those around me made it out to be a big deal, they were upset. I chose to not dwell on the implications.”

“Whatever comes, goes,” is a Hindu philosophy that may be applied to the cycle of life and also to situations, somewhat on the lines of “this too shall pass” or “nothing lasts forever.”

Kanti says this philosophy helped her see Parkinson’s as “just another situation that is as impermanent as the body.”

“I wanted to be invincible, to not be bothered in the mind because that’s where the negativity starts—the fear, the self-pity or the depression. We’re all going to face some obstacles in life. What matters is how you face them.”

Kanti faced her obstacles by coming closer to God, she says. “I’d been meditating for decades before my Parkinson’s diagnosis but the condition deepened my connection with the Divine.”

One day while sitting on the top floor of a double-decker bus, Kanti remembers drawing a fire on her iPad. “I had been thinking about the concept of ‘the fire of meditation’, in the sense that meditation is a tool to introspect and change deep-seated habits.”

Doodling on her iPad and taking photographs of flowers were two fascinations that Kanti kept up with even after her Parkinson’s diagnosis, driven by her innate love for the art of presentation.

“I have always been attracted by the art of presentation,” she says. “I taught cookery in the eighties, and would have demonstrations of Indian cooking at home for groups of 12-20 people. The elements of design in food presentation and flower arrangements is something I enjoy. It’s a creative hobby.”

That experience drew Kanti to art when in 2015, she was “looking for something to fill my life and to get away from the isolation that sometimes hit me,” she says. “By then I’d experienced the pitiful looks, the ‘what-have-you-done-to-get-Parkinson’s’ looks, and I believe, I had held up pretty well against the odds.”

But still, sometimes, I had this nagging thought of proving myself.

“I decided to try my hand at painting, and that worked for me from the word go,” she says. “The beauty is I would get fully immersed in the colours and the form, it was the perfect release. While I was painting, the tremors ceased. And I could be so creative.”

One of Kanti Khanna's paintings - pink flowers on a blue background
Flowers are a recurring theme in Kanti’s art

At the outset, flowers were a recurring theme in Kanti’s art but she became bolder after a friend who is an art consultant once remarked on seeing one of her paintings: “I would pay Pounds 400 for that.”

“I had never thought of selling my work,” says Kanti. “I was just painting for the love of it. But the fact that someone put a value to my work gave me a boost.”

Kanti gradually switched to themes associated with her interest in spirituality and meditation.

“My art looks abstract but it is actually themed on my understanding of life,” she says. “I believe the soul is like a sparkling point of energy, a star, if you will; that’s why you see a lot of use of jewels and stones and glitter in my art.”

“I believe the soul is like a sparkling point of energy, a star, if you will; that’s why you see a lot of use of jewels and stones and glitter in my art.”

“Many of my paintings are representations of the brotherhood of souls, or the home of souls, you could say. I am also attracted to trees, from the concept of the ‘tree of life’.”

Kanti’s work brings to life the walls of her home in Birmingham, UK. But with no plans to sell her work, her husband and she soon ran out of place to showcase her best effort. “I presented a few paintings to friends and family. Once when a friend was decorating a home, she asked for a few pieces, and we agreed that she would pay the cost of the materials.”

Another of Kanti’s textured, jewel-adorned paintings

Kanti remembers a time she left home to visit a meditation centre without her purse. “Forgetfulness and falls were two downsides I had to learn to contend with,” she says. “I realised I had no money when the ticket collector came round. He knew me well, and he knew I had Parkinson’s. Not just he, all the regulars on the bus knew of my condition. But that didn’t help. I needed a ticket. So I asked a woman seated near me, a regular, if I could borrow a pound. Of course she was happy to help.”

“The next time I boarded the bus, I had a painting for her.”

“Yes, she loved it. And yes, such moments reaffirm my belief that Parkinson’s isn’t a constraint to living a full life.”

Find out more about creativity and Parkinson’s

Parkinson’s and women: new global initiative to explore unique impact

Critical Path Institute announce a landmark initiative, Gender Equitable Medicines for Parkinson’s Disease, dedicated to advancing actionable research on how Parkinson’s affects women
20 November 2024 Sarah Dawson
News

Non-profit Critical Path Institute (C-Path) plans to focus on a long-overlooked area of research – the different ways Parkinson’s uniquely affects women and individuals across the sex and gender spectrum.

Since its launch in 2005, the independent, non-profit has pioneered advancing better treatments and drug development. The Gender Equitable Medicines for Parkinson’s Disease (GEM-PD) initiative will use diverse data and innovative technologies, including artificial intelligence and digital health technologies, to help accelerate the development of more personalised treatments.

The initiative will also focus on drug development to help provide a more equitable approach to detection, disease management and therapies for all individuals living with Parkinson’s.

C-Path CEO Klaus Romero, M.D., M.S., FCP, says: “GEM-PD will further catalyse our efforts to address unmet need in Parkinson’s disease therapies.”

Sarah Zenner-Dolan, Parkinson’s patient, and C-Path advisor, adds: “As someone living with Parkinson’s, I’m hopeful that through a better understanding of how the disease affects women uniquely — from disease onset to clinical diagnosis and treatment response — we can develop treatments that truly reflect each person’s unique experience. This initiative gives me hope that future therapies will better address the specific challenges women face with Parkinson’s.”

Building on the work of CPP

GEM-PD will partner with and build upon the achievements of C-Path’s Critical Path for Parkinson’s (CPP) Consortium.

Amelia Hursey, Research Manager at Parkinson’s Europe explains: “CPP is a global consortium gathering data from all of its stakeholders so we can collectively understand more about Parkinson’s and work towards finding a cure. Each initiative that comes out of CPP is going to help the Parkinson’s community, and gender differences are a very important part of that picture.”

Collaboration and data sharing are crucial to driving innovation. CPP’s global database has already had an impact on drug development, by examining how factors such as biomarkers and genetics shape the living experiences of those with Parkinson’s.

Over the last 10 years, CPP has achieved significant success, including the first biomarker qualified by the European Medicines Agency for use in clinical trials targeting early-stage of disease. Working in partnership with CPP, C-Path’s GEM-PD initiative aims to continue this progress to develop more tailored solutions for the Parkinson’s community.

woman smiling and sitting with grandchildren

Women-focused initiative to help fill research gaps

“The launch of GEM-PD is a major step in addressing the gaps in Parkinson’s research,” said Diane Stephenson, Ph.D., Vice President of Neurology, and Executive Director of CPP. “By focusing on women’s distinctive experiences, we’re filling a critical need for more personalised approaches to treatment. This initiative not only strengthens our existing tools and databases but also creates new opportunities for innovation.”

Gender specific research in Parkinson’s is hugely important, and something Cathy Molohan – observer on the Parkinson’s Europe Board – feels strongly about: “I’m delighted to see that the topic of gender and Parkinson’s is being addressed,” she shares. “It is essential that we understand the impact of hormones on women’s symptoms, and that we can adjust treatment accordingly. Women experience very different symptoms to men and metabolise medication differently. It’s high time we do more to understand these differences and stop treating men and women the same. There is a lot of hype at the moment about personalised medicine, and yet we are failing to personalise treatment at the most basic level – that of gender.”

Experts welcome unique gender focus

The initiative has been received positively by experts within the Parkinson’s community, including Dr Soania Mathur, a Toronto-based PwP and Parkinson’s advocate who has been passionately involved in supporting additional research in women and Parkinson’s and the research gap.

“For too long women living with Parkinson’s disease have not had their unique experience with this disease recognised and there are a number of unmet needs in this part of our community,” she explains. “Not only are there differences in the physical manifestation of Parkinson’s but also a significant difference in the emotional experience and the psychosocial stressors that women face. So to see efforts directed towards unique gender experiences and the development of personalised approaches to care is long overdue.”

Richelle Flanagan, the inventor of the Parkinson’s self-care app My Moves Matter and a woman living with Parkinson’s, echoes this opinion, saying: “Over the last five years, through co-founding the Women’s Parkinson’s Project and the My Moves Matter app, I have been advocating for better personalised care for women with Parkinson’s. We can see in the aggregated data from My Moves Matter differences in the patient reported symptom tracking between women and men,” she says.

“We would be delighted to collaborate with this great initiative by C-Path to accelerate better management of women with the drugs we have today. But also to help identify new pathways to slow progression for both women and men, through a better understanding of the pathology of Parkinson’s through a sex-specific lens.”

You can find out more about C-Path and the Gender Equitable Medicines for Parkinson’s Disease (GEM-PD) initiative at C-Path.org